INSYS Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference
03 Janeiro 2019 - 9:00AM
INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the
development, manufacture and commercialization of pharmaceutical
cannabinoids and spray technology, announced today that Saeed
Motahari, president and chief executive officer, and Andy Long,
chief financial officer, will present at the J.P. Morgan Healthcare
Conference as follows:
|
|
Date:
|
Thursday, January 10th,
2019 |
Time: |
10:30 a.m. Pacific
Standard Time |
Location: |
Westin St. Francis
Hotel, San Francisco, California |
|
|
The presentation will be webcast live at the above-mentioned
time, and archived for 30 days thereafter, via the Investors
section of company’s website at https://www.insysrx.com/, under
Presentations & Events. Accessible at the same webpage, the
presentation slides will be available during and after the
conference.
About INSYSINSYS Therapeutics is a specialty
pharmaceutical company that develops and commercializes innovative
drugs and novel drug delivery systems of therapeutic molecules that
improve patients’ quality of life. Using proprietary spray
technology and capabilities to develop pharmaceutical cannabinoids,
INSYS is developing a pipeline of products intended to address
unmet medical needs and the clinical shortcomings of existing
commercial products. INSYS is committed to developing medications
for potentially treating anaphylaxis, epilepsy, Prader-Willi
syndrome, opioid addiction and overdose, and other disease areas
with a significant unmet need.
|
|
CONTACT: |
Investor
Relations & Corporate Communications |
|
Jackie Marcus or Chris
Hodges |
|
Alpha IR Group |
|
312-445-2870 |
|
INSY@alpha-ir.com |
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Insys Therapeutics, Inc. da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de